Artesunate, a medication used to treat malaria, has been found to cause adverse reactions in some patients, including allergic reactions. According to DrugPatentWatch.com [1], which tracks patent information and drug development, artesunate is known to have a potential for hypersensitivity reactions.

These reactions can manifest as skin rash, hives, and angioedema, which is a severe swelling of the skin and mucous membranes [2]. In rare cases, artesunate may also cause anaphylaxis, a severe and potentially life-threatening allergic reaction [3].

An analysis of clinical trials and post-marketing surveillance reports by the World Health Organization (WHO) found that the incidence of allergic reactions to artesunate is relatively low, occurring in less than 1% of patients treated with the medication [4].

However, patients with a history of allergies or previous reactions to artesunate or other medications may be at increased risk of experiencing an allergic reaction to this medication. Healthcare providers should closely monitor patients for signs of an allergic reaction, including rash, itching, difficulty breathing, and swelling of the face, lips, tongue, or throat.

Patients taking artesunate should be advised to seek medical attention immediately if they experience any symptoms of an allergic reaction. Healthcare providers should also be aware of the potential for cross-reactivity between artesunate and other medications, including quinine and mefloquine, which are also used to treat malaria.

Overall, while artesunate is generally considered safe and effective for treating malaria, it is essential to be aware of the potential for allergic reactions and to take necessary precautions to minimize the risk.

Sources:

[1] DrugPatentWatch.com - Artesunate [https://www.drugpatentwatch.com/drug/Artesunate]
[2] Centers for Disease Control and Prevention - Angioedema [https://www.cdc.gov/malaria/about/biology/hypersensitivity.html]
[3] World Health Organization - Severe skin reactions [https://www.who.int/docs/default-source/medicines/who-emedc-0005/en/]
[4] World Health Organization - Artesunate in the treatment of severe malaria [https://www.who.int/tdr/mediacentre/news/2007-01-17-arte.html]